St. Elisabeth Gruppe GmbH - Katholische Kliniken Rhein-Ruhr

Diagnostik und Therapie des Ulcus cruris venosum: S2k-Leitlinie der Deutschen Gesellschaft für Phlebologie und Lymphologie (DGPL) e.V. (2024) Valesky EM, Hach-Wunderle V, Protz K, Zeiner KN, Erfurt-Berge C, Goedecke F, Jäger B, et al. Journal article Diagnosis and treatment of venous leg ulcers: S2k Guideline of the German Society of Phlebology and Lymphology (DGPL) e.V. (2024) Valesky EM, Hach-Wunderle V, Protz K, Zeiner KN, Erfurt-Berge C, Goedecke F, Jäger B, et al. Journal article ESPEN guideline on nutrition and hydration in dementia – Update 2024 (2024) Volkert D, Beck AM, Faxén-Irving G, Frühwald T, Hooper L, Keller H, Porter J, et al. Journal article [German expert consensus on programmed cell death ligand 1 (PD-L1) testing in perioperative systemic therapy of muscle invasive bladder cancer]. (2024) Niegisch G, Bolenz C, Doehn C, Gakis G, Hartmann A, Müller-Huesmann H, Reis H, et al. Journal article, Review article Pre-treatment metastatic biopsy: a step towards precision oncology for urothelial cancer (2024) Klümper N, Cox A, Sjödahl G, Roghmann F, Bolenz C, Hartmann A, Grünwald V, et al. Journal article, Review article Role and benefits of infectious diseases specialists in the COVID-19 pandemic: Multilevel analysis of care provision in German hospitals using data from the Lean European Open Survey on SARS-CoV-2 infected patients (LEOSS) cohort (2024) Tscharntke LT, Jung N, Hanses F, Koll CE, Pilgram L, Rieg S, Borgmann S, et al. Journal article An Empirical Survey on the Adaption of Neoadjuvant Chemotherapy in Bladder Cancer (2024) Reike MJ, Reicherz A, Tully KH, Bahlburg H, Maas M, Bach P, Klümper N, et al. Journal article Nivolumab + Ipilimumab as Immunotherapeutic Boost in Metastatic Urothelial Carcinoma: A Nonrandomized Clinical Trial (2024) Grimm MO, Schostak M, Grün CB, Loidl W, Pichler M, Zimmermann U, Schmitz-Dräger BJ, et al. Journal article Improving detection of carcinoma in situ in bladder cancer: urinary cytology vs the Xpert® BC Monitor (2024) Haas M, Kriegmair MC, Breyer J, Sikic D, Wezel F, Roghmann F, Brehmer M, et al. Journal article Simulation of the effects of molecular urine markers in follow-up of patients with high-risk non-muscle invasive bladder cancer (2024) Benderska-Söder N, Ecke T, Kleinlein L, Roghmann F, Bismarck E, van Rhijn BWG, Stenzl A, et al. Journal article, Review article